Royal Fox Gold Inc.
HBEXF
OTC PK
Weiss Ratings | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | E | |||
Rating Factors | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Fair | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.00 | |||
Price History | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 0.00% | |||
60-Day Total Return | 0.00% | |||
90-Day Total Return | 0.00% | |||
Year to Date Total Return | 0.00% | |||
1-Year Total Return | 0.00% | |||
2-Year Total Return | 0.00% | |||
3-Year Total Return | 0.33% | |||
5-Year Total Return | -28.33% | |||
52-Week High % Change | 0.00% | |||
52-Week Low % Change | 0.00% | |||
Price | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.03 | |||
52-Week Low Price | $0.03 | |||
52-Week Low Price (Date) | Mar 18, 2025 | |||
52-Week High Price (Date) | Mar 18, 2025 | |||
Valuation | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | -- | |||
Enterprise Value | -- | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | -74.64% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -4.70 | |||
Enterprise Value/Revenue (TTM) | 6,582.33 | |||
Price | $0.03 | |||
Enterprise Value/EBITDA (TTM) | -- | |||
Enterprise Value/EBIT | -9.90 | |||
Market Cap Category | -- | |||
Dividends and Shares | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 296.47M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | -- | |||
Address | 401-217 Queen Street West Toronto, ON M5V 0R2 | |||
Website | -- | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -66,493.33% | |||
Profit Margin | -69,473.33% | |||
Management Effectiveness | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -70.56% | |||
Return on Equity | -- | |||
Income Statement | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | 1.50K | |||
Revenue Per Share | $0.00 | |||
Gross Profit (TTM) | 1.50K | |||
EBITDA (TTM) | -- | |||
EBIT (TTM) | -997.40K | |||
Net Income (TTM) | -1.04M | |||
Net Income Avl. to Common (TTM) | -1.04M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | 87.20% | |||
EPS Diluted (TTM) | 0.00 | |||
EPS Diluted Growth (Q YOY) | 88.24% | |||
Balance Sheet | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 308.80K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 445.20K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | -1.90M | |||
Current Ratio (Q) | 0.184 | |||
Book Value Per Share (Q) | -$0.01 | |||
Total Assets (Q) | 517.60K | |||
Total Current Liabilities (Q) | 2.42M | |||
Total Debt (Q) | 0.00 | |||
Total Liabilities (Q) | 2.42M | |||
Total Common Equity (Q) | -1.90M | |||
Cash Flow | HBEXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -- | |||
Cash from Financing (TTM) | 468.30K | |||
Net Change in Cash (TTM) | -406.90K | |||
Levered Free Cash Flow (TTM) | -4.60K | |||
Cash from Operations (TTM) | -875.20K | |||